HomeInsights52 Week Low Stocks

Mankind Pharma Ltd 52 Week Low

Mankind Pharma Ltd 52 Week Low

stocks purchased

₹ 2.2 Cr

Volume Transacted

(Nov 21, 2024)

stocks purchased

8.7 K

Stocks Traded

(Nov 21, 2024)

Last Updated on: Nov 22, 2024

Image

Mankind Pharma Ltd

NSE: MANKIND

YEARLOW

₹ 1820.15

Last updated on: Nov 21, 2024

Key Highlights

  • The 52 Week Low of Mankind Pharma Ltd is ₹ 1820 as of 21 Nov 24 .

Company Fundamentals for Mankind Pharma Ltd

No data available

Market Price of Mankind Pharma Ltd

1M

1Y

3Y

5Y

Monitoring Mankind Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
21 Nov 20242552.6
19 Nov 20242568
18 Nov 20242599.95
14 Nov 20242606
13 Nov 20242530.95
12 Nov 20242628.35
11 Nov 20242646.05
08 Nov 20242658.9
07 Nov 20242726.45
06 Nov 20242750.1

Asset Value vs Market Value of Mankind Pharma Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Historical Revenue of Mankind Pharma Ltd

No data available

* All values are in crore

Historical Net Profit of Mankind Pharma Ltd

No data available

* All values are in crore

Mankind Pharma Ltd News Hub

News

Mankind Pharma Ltd slips for fifth straight session

Mankind Pharma Ltd dropped for a fifth straight session today. The stock is quoting at Rs ...

Read more

13 Nov 202413:14

News

Mankind Pharma receives reaffirmation in credit rating from CRISIL

Mankind Pharma has received reaffirmation in credit ratings from CRISIL as under: Commerci...

Read more

06 Nov 202413:15

News

Mankind Pharma hits life high after Q2 PAT jumps 30% YoY to Rs 653 cr

Profit before tax was at Rs 849.32 crore in Q2 FY25, registering a growth of 32.5% from Rs...

Read more

06 Nov 202410:03

News

Mankind Pharma Ltd spurts 0.01%, up for fifth straight session

Mankind Pharma Ltd is up for a fifth straight session today. The stock is quoting at Rs 26...

Read more

04 Nov 202413:00

News

Mankind Pharma Ltd spurts 3.89%

Mankind Pharma Ltd is up for a third straight session in a row. The stock is quoting at Rs...

Read more

31 Oct 202413:05

News

Mankind Pharma to convene board meeting

Mankind Pharma will hold a meeting of the Board of Directors of the Company on 5 November ...

Read more

25 Oct 202416:07

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for 52 Week Low of Mankind Pharma Ltd

Why is it important to track the 52-week low of Mankind Pharma Ltd stocks?

Investors should monitor the 52-week low of Mankind Pharma Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time. Frequent monitoring will help traders identify trends and make timely decisions.

What factors can lead to Mankind Pharma Ltd stocks hitting a 52-week low?

Factors leading to Mankind Pharma Ltd stocks hitting a 52-week low may include poor fiscal results, negative industry trends, macroeconomic issues, or management changes. Other factors such as market volatility and broader economic downturns can also contribute to a 52-week low.

Should investors buy Mankind Pharma Ltd stocks when they hit a 52-week low?

Buying Mankind Pharma Ltd stocks at a 52-week low can offer a potential bargain, however, it is crucial to evaluate the reasons behind the stock price drop and ensure there is no underlying fundamental issue. Investors should consider the company's long-term prospects before making a buying decision.

How often should investors monitor the 52-week low of Mankind Pharma Ltd stocks?

Investors should monitor the 52-week low of Mankind Pharma Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time, which will help them identify trends and make timely decisions.

How can an investor assess the risk of buying Mankind Pharma Ltd stock at their 52-week low?

An investor can analyze the reasons for the Mankind Pharma Ltd stock price drop, evaluate the company’s fundamentals, and consider market conditions. Investors should also review the stock’s historical performance and any potential recovery indicators.

Should investors consider the overall market trend when evaluating Mankind Pharma Ltd stocks at their 52-week low?

Certainly, considering the overall market trend when evaluating Mankind Pharma Ltd stocks at their 52-week low is significant as it provides context for the stock’s performance and potential future movements. A declining market trend may influence Mankind Pharma Ltd stock performance, impacting the timing and potential of the investment.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*